IntraVagS301
Endometriosis
Phase 1Active
Key Facts
About Gynica
Israeli startup developing vaginal cannabinoid treatments for endometriosis with a microencapsulation delivery platform.
View full company profileTherapeutic Areas
Other Endometriosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Promarker™Endo | Proteomics International | Late‑stage validation |
| EV‑Endo | Cartherics | Preclinical |
| Endometriosis Program | Cyclana Bio | Discovery |
| Endometriosis Genetic Study | Juneau Biosciences | Discovery |
| Potential Diagnostic Development | Juneau Biosciences | Research |
| Endometriosis Discovery Program | Metri Bio | Discovery |
| Endometriosis Test Suite | Heranova Lifesciences | Pre-clinical |
| EndomTest | Kephera Diagnostics | Commercial (LDT) |
| ENDO-205 | EndoCyclic Therapeutics | Phase 1 |
| Undisclosed Immunotherapy | Apheon Bioscience | Preclinical |
| FMC | FimmCyte | Pre-clinical |
| ABC-201 | Abcely | Preclinical |